<p>Therapeutic immunization: mice were challenged with 2×10<sup>5</sup> TC-1 cells on day 0 and vaccinated twice on day 10 and 17. Preventive immunization: mice were vaccinated on day 0 and day 14, and then challenged with 6×10<sup>4</sup> TC-1 cells on day 28. Tumor size was recorded twice or thrice a week.</p
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p><b>A</b>: Schematic diagram of the therapeutic vaccination Two groups of BALB/c mice (n = 7) were...
<p><b>A)</b> Top, vaccination schedule. Bottom, tumor survival data (n = 10). Black star corresponds...
<p><b>A)</b> Top, vaccination schedule. Bottom; tumor survival data (n = 9). Black star corresponds ...
<p>A: Schematic diagram of the prophylactic vaccination. Two groups of BALB/c mice (n = 7) were immu...
<p>5-week old BALB/c mice were immunized three times with different antigens at two-week interval. S...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
<p>Five groups of mice (groups of 6) were immunized with different regimens of QH and/or SX H5N1 HA ...
<p><b>A</b>. Schematic showing the vaccination protocol. Mice were vaccinated by gene-gun twice at 3...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>420 mice were divided into animals that were uninfected (NC-UU) (20 mice) and those that were inf...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>(A) Schematic diagram depicting the regimen. On Day 1, TC-1 cells were injected subcutaneously. F...
<p><b>A</b>: Schematic diagram of the therapeutic vaccination Two groups of BALB/c mice (n = 7) were...
<p><b>A)</b> Top, vaccination schedule. Bottom, tumor survival data (n = 10). Black star corresponds...
<p><b>A)</b> Top, vaccination schedule. Bottom; tumor survival data (n = 9). Black star corresponds ...
<p>A: Schematic diagram of the prophylactic vaccination. Two groups of BALB/c mice (n = 7) were immu...
<p>5-week old BALB/c mice were immunized three times with different antigens at two-week interval. S...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
<p>Five groups of mice (groups of 6) were immunized with different regimens of QH and/or SX H5N1 HA ...
<p><b>A</b>. Schematic showing the vaccination protocol. Mice were vaccinated by gene-gun twice at 3...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>420 mice were divided into animals that were uninfected (NC-UU) (20 mice) and those that were inf...
<p>(A) Vaccination schedule. (B) Mice (n = 5) were immunized with various DNA vaccines and challenge...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
<p>A/J mice were inoculated with 1 × 10<sup>6</sup> wild-type (WT) N2a, and once tumors were establi...
Analysis of anti-tumor immunity for prophylactic effect. EG7-OVA tumor cells (1×105 cells) were inoc...
DOI
Add to ORKG